Top Key Companies for HER2 Testing Market: Abbott, Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Leica Biosystems (Danaher Corporation), Empire Genomics, Inc. (Biocare Medical, LLC), Bio-Genex Laboratories, Abnova Corporation, Oxford Gene Technology IP Limited (Sysmex Corporation).
Global HER2 Testing Market Size was estimated at USD 21.85 million in 2022 and is projected to reach USD 16.52 million by 2028, exhibiting a CAGR of -4.55% during the forecast period.
Global HER2 Testing Market Overview And Scope:
The Global HER2 Testing Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of HER2 Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global HER2 Testing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global HER2 Testing market.
Global HER2 Testing Market Segmentation
By Type, HER2 Testing market has been segmented into:
Fluorescence In Situ Hybridization
Dual-Probe
Single-Probe
Chromogenic In Situ Hybridization (CISH)
Silver-Enhanced In Situ Hybridization
By Application, HER2 Testing market has been segmented into:
Hospitals
Diagnostic Laboratories
Others
Regional Analysis of HER2 Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of HER2 Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The HER2 Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the HER2 Testing market.
Top Key Companies Covered in HER2 Testing market are:
Abbott
Hoffmann-La Roche Ltd
Agilent Technologies
Inc.
Thermo Fisher Scientific
Inc.
Leica Biosystems (Danaher Corporation)
Empire Genomics
Inc. (Biocare Medical
LLC)
Bio-Genex Laboratories
Abnova Corporation
Oxford Gene Technology IP Limited (Sysmex Corporation)
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: HER2 Testing Market by Type
5.1 HER2 Testing Market Overview Snapshot and Growth Engine
5.2 HER2 Testing Market Overview
5.3 Fluorescence In Situ Hybridization
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Fluorescence In Situ Hybridization: Geographic Segmentation
5.4 Dual-Probe
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Dual-Probe: Geographic Segmentation
5.5 Single-Probe
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Single-Probe: Geographic Segmentation
5.6 Chromogenic In Situ Hybridization (CISH)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Chromogenic In Situ Hybridization (CISH): Geographic Segmentation
5.7 Silver-Enhanced In Situ Hybridization
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Silver-Enhanced In Situ Hybridization: Geographic Segmentation
Chapter 6: HER2 Testing Market by Application
6.1 HER2 Testing Market Overview Snapshot and Growth Engine
6.2 HER2 Testing Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Diagnostic Laboratories
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Laboratories: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 HER2 Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 HER2 Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 HER2 Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 HOFFMANN-LA ROCHE LTD
7.4 AGILENT TECHNOLOGIES
7.5 INC.
7.6 THERMO FISHER SCIENTIFIC
7.7 INC.
7.8 LEICA BIOSYSTEMS (DANAHER CORPORATION)
7.9 EMPIRE GENOMICS
7.10 INC. (BIOCARE MEDICAL
7.11 LLC)
7.12 BIO-GENEX LABORATORIES
7.13 ABNOVA CORPORATION
7.14 OXFORD GENE TECHNOLOGY IP LIMITED (SYSMEX CORPORATION)
Chapter 8: Global HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Fluorescence In Situ Hybridization
8.2.2 Dual-Probe
8.2.3 Single-Probe
8.2.4 Chromogenic In Situ Hybridization (CISH)
8.2.5 Silver-Enhanced In Situ Hybridization
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Diagnostic Laboratories
8.3.3 Others
Chapter 9: North America HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Fluorescence In Situ Hybridization
9.4.2 Dual-Probe
9.4.3 Single-Probe
9.4.4 Chromogenic In Situ Hybridization (CISH)
9.4.5 Silver-Enhanced In Situ Hybridization
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Diagnostic Laboratories
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Fluorescence In Situ Hybridization
10.4.2 Dual-Probe
10.4.3 Single-Probe
10.4.4 Chromogenic In Situ Hybridization (CISH)
10.4.5 Silver-Enhanced In Situ Hybridization
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Diagnostic Laboratories
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Fluorescence In Situ Hybridization
11.4.2 Dual-Probe
11.4.3 Single-Probe
11.4.4 Chromogenic In Situ Hybridization (CISH)
11.4.5 Silver-Enhanced In Situ Hybridization
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Diagnostic Laboratories
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Fluorescence In Situ Hybridization
12.4.2 Dual-Probe
12.4.3 Single-Probe
12.4.4 Chromogenic In Situ Hybridization (CISH)
12.4.5 Silver-Enhanced In Situ Hybridization
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Diagnostic Laboratories
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Fluorescence In Situ Hybridization
13.4.2 Dual-Probe
13.4.3 Single-Probe
13.4.4 Chromogenic In Situ Hybridization (CISH)
13.4.5 Silver-Enhanced In Situ Hybridization
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Diagnostic Laboratories
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America HER2 Testing Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Fluorescence In Situ Hybridization
14.4.2 Dual-Probe
14.4.3 Single-Probe
14.4.4 Chromogenic In Situ Hybridization (CISH)
14.4.5 Silver-Enhanced In Situ Hybridization
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Diagnostic Laboratories
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
HER2 Testing Scope:
|
Report Data
|
HER2 Testing Market
|
|
HER2 Testing Market Size in 2025
|
USD XX million
|
|
HER2 Testing CAGR 2025 - 2032
|
XX%
|
|
HER2 Testing Base Year
|
2024
|
|
HER2 Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Leica Biosystems (Danaher Corporation), Empire Genomics, Inc. (Biocare Medical, LLC), Bio-Genex Laboratories, Abnova Corporation, Oxford Gene Technology IP Limited (Sysmex Corporation).
|
|
Key Segments
|
By Type
Fluorescence In Situ Hybridization
Dual-Probe
Single-Probe
Chromogenic In Situ Hybridization (CISH)
Silver-Enhanced In Situ Hybridization
By Applications
Hospitals
Diagnostic Laboratories
Others
|
